PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ARCA Pharmaceutical Index (^DRG)
Performance
Risk-Adjusted Performance
Drawdowns
Volatility

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


ARCA Pharmaceutical Index

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in ARCA Pharmaceutical Index, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-5.00%0.00%5.00%10.00%AprilMayJuneJulyAugustSeptember
7.60%
6.71%
^DRG (ARCA Pharmaceutical Index)
Benchmark (^GSPC)

S&P 500

Returns By Period

ARCA Pharmaceutical Index had a return of 21.69% year-to-date (YTD) and 23.43% in the last 12 months. Over the past 10 years, ARCA Pharmaceutical Index had an annualized return of 7.74%, while the S&P 500 had an annualized return of 10.67%, indicating that ARCA Pharmaceutical Index did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date21.69%15.38%
1 month6.72%5.03%
6 months7.60%6.71%
1 year23.43%23.24%
5 years (annualized)13.57%13.10%
10 years (annualized)7.74%10.67%

Monthly Returns

The table below presents the monthly returns of ^DRG, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20244.91%5.14%2.22%-2.74%3.07%3.23%-1.25%8.71%21.69%
2023-3.60%-3.91%4.67%4.09%-3.35%3.23%0.19%3.45%-2.58%-2.99%3.50%2.72%4.87%
2022-3.74%-1.55%6.25%-0.51%1.81%-1.07%-0.98%-8.56%-2.03%8.54%7.26%0.53%4.74%
20211.39%-2.58%1.81%1.58%3.15%2.33%3.27%2.52%-6.37%5.58%-2.68%9.41%20.18%
2020-1.07%-8.15%-2.40%10.55%2.50%-2.54%2.49%2.66%-1.95%-7.18%9.24%2.94%5.48%
20190.23%3.59%2.02%-2.83%-3.44%5.87%-2.92%0.13%0.90%3.88%2.51%4.58%14.92%
20183.59%-4.65%-1.73%-0.85%-0.04%0.62%7.75%1.94%2.46%-3.31%6.13%-6.63%4.38%
2017-0.35%6.58%-0.51%0.62%2.35%2.35%-0.82%-0.38%2.83%-2.06%1.72%0.39%13.16%
2016-5.78%-4.39%1.21%3.25%1.83%1.90%4.54%-5.93%-1.70%-7.03%-1.18%2.54%-11.06%
20151.55%4.66%0.56%1.24%2.22%-2.71%5.43%-8.12%-5.83%4.17%-1.62%1.03%1.62%
2014-0.01%8.00%-0.74%2.67%-0.80%2.32%-2.64%2.86%1.77%-0.45%3.84%-3.29%13.83%
20136.88%-0.65%5.14%3.68%-1.53%-1.74%4.69%-3.22%2.63%3.95%3.49%1.11%26.65%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current risk-adjusted rank of ^DRG is 75, placing it in the top 25% of indices on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.


The Risk-Adjusted Performance Rank of ^DRG is 7575
^DRG (ARCA Pharmaceutical Index)
The Sharpe Ratio Rank of ^DRG is 7171Sharpe Ratio Rank
The Sortino Ratio Rank of ^DRG is 7373Sortino Ratio Rank
The Omega Ratio Rank of ^DRG is 7373Omega Ratio Rank
The Calmar Ratio Rank of ^DRG is 9393Calmar Ratio Rank
The Martin Ratio Rank of ^DRG is 6767Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for ARCA Pharmaceutical Index (^DRG) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


^DRG
Sharpe ratio
The chart of Sharpe ratio for ^DRG, currently valued at 1.69, compared to the broader market-0.500.000.501.001.502.001.69
Sortino ratio
The chart of Sortino ratio for ^DRG, currently valued at 2.34, compared to the broader market-1.000.001.002.002.34
Omega ratio
The chart of Omega ratio for ^DRG, currently valued at 1.31, compared to the broader market0.901.001.101.201.301.401.31
Calmar ratio
The chart of Calmar ratio for ^DRG, currently valued at 2.60, compared to the broader market0.001.002.003.004.002.60
Martin ratio
The chart of Martin ratio for ^DRG, currently valued at 7.57, compared to the broader market0.005.0010.0015.007.57
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 1.78, compared to the broader market-0.500.000.501.001.502.001.78
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.44, compared to the broader market-1.000.001.002.002.44
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.32, compared to the broader market0.901.001.101.201.301.401.32
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.58, compared to the broader market0.001.002.003.004.001.58
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 8.48, compared to the broader market0.005.0010.0015.008.48

Sharpe Ratio

The current ARCA Pharmaceutical Index Sharpe ratio is 1.69. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of ARCA Pharmaceutical Index with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio1.001.502.002.503.00AprilMayJuneJulyAugustSeptember
1.69
1.78
^DRG (ARCA Pharmaceutical Index)
Benchmark (^GSPC)

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-8.00%-6.00%-4.00%-2.00%0.00%AprilMayJuneJulyAugustSeptember
-2.86%
-2.89%
^DRG (ARCA Pharmaceutical Index)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the ARCA Pharmaceutical Index. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the ARCA Pharmaceutical Index was 51.48%, occurring on Mar 3, 2009. Recovery took 1172 trading sessions.

The current ARCA Pharmaceutical Index drawdown is 2.86%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-51.48%Nov 30, 20002073Mar 3, 20091172Oct 25, 20133245
-32.69%Aug 5, 1992259Aug 12, 1993435May 3, 1995694
-31.21%Apr 13, 1999229Mar 7, 200087Jul 11, 2000316
-26.25%Jan 21, 202044Mar 23, 202081Jul 17, 2020125
-23.46%Aug 6, 2015334Dec 1, 2016501Nov 30, 2018835

Volatility

Volatility Chart

The current ARCA Pharmaceutical Index volatility is 5.29%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%7.00%AprilMayJuneJulyAugustSeptember
5.29%
4.56%
^DRG (ARCA Pharmaceutical Index)
Benchmark (^GSPC)